MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates January 31, 2019
AJANTA PHARMA Plunges by 5%; BSE HEALTHCARE Index Up 0.2%
Thu, 31 Jan 09:20 AM
AJANTA PHARMA share price has plunged 5% and is presently trading at Rs 1,035.
Meanwhile, the BSE HEALTHCARE Index is at 13,792 (up 0.2%).
Among the top losers in the BSE HEALTHCARE Index today is AJANTA PHARMA (down 5.0%).
DR. LAL PATHLABS LTD (up 4.0%) and NATCO PHARMA (up 3.1%) are among the top gainers today.
Over the last one year, AJANTA PHARMA has moved down from Rs 1,449 to Rs 1,035, registering a loss of Rs 415 (down 28.6%)..
The BSE HEALTHCARE has moved down from 14,800 to 13,792, loss of 1,008 points (down 6.8%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 45.3%), TORRENT PHARMA (up 39.8%) and IPCA LABS (up 39.2%).
What About the Benchmark Indices?
The BSE Sensex is at 35,806 (up 0.6%). The top gainers among the BSE Sensex stocks today are ICICI BANK (up 2.0%). The most traded stocks in the BSE Sensex are INDUSIND BANK and AXIS BANK.
In the meantime, NSE Nifty is at 10,691 (up 0.4%). ICICI BANK (up 1.9%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 36,034 to 35,806, registering a gain of -228 points (up -0.6%).
AJANTA PHARMA Financial Update...
AJANTA PHARMA net profit down at Rs 1 billion for the quarter ended September 2018, compared to a loss of Rs 1 billion a year ago. Net Sales declined 7.3% to Rs 5.4 billion during the period as against Rs 5.9 billion in July-September 2017.
For the year ended March 2018, AJANTA PHARMA reported 7.5% decrease in net profit to Rs 4.7 billion compared to net profit of Rs 5.1 billion during FY17.
Revenue of the company grew 6.5% to Rs 21 billion during FY18.
The current Price to earnings ratio of AJANTA PHARMA, based on rolling 12 month earnings, stands at 19.4x.
Indian Share Market Update: Top Gainers and Losers
|
| |
Stock Market Updates
Top 5 Mid-Cap Gainers Today; MAX FINANCIAL SERVICES LTD Leads the Pack (Today's Market)
Aug 20, 2019 04:39 PMHere's a list of 5 stocks that gained the most in the BSE Mid-Cap Index today. It also includes information on BSE Mid-Cap index and the broader benchmark indices.
Sensex Ends 74 Points Lower; Metal and Energy Stocks Witness Selling (Today's Market)
Aug 20, 2019 ClosingIndia share markets ended their volatile trading session marginally lower today. At the closing bell, the BSE Sensex stood lower by 74 points (down 0.2%).
PARAG MILK FOODS LTD Plunges by 5%; BSE 500 Index Down 0.3% (Today's Market)
Aug 20, 2019 03:34 PMPARAG MILK FOODS LTD share price has plunged by 5% and its current market price is Rs 169. The BSE 500 is down by 0.3%. The top gainers in the BSE 500 Index are MAHANAGAR GAS (up 7.8%) and JAGRAN PRAKASHAN (up 5.2%). The top losers are PARAG MILK FOODS LTD (down 5.3%) and EDELWEISS FINANCIAL (down 8.8%).
NIIT TECHNOLOGIES Surges by 5%; BSE IT Index Up 1.4% (Today's Market)
Aug 20, 2019 03:32 PMNIIT TECHNOLOGIES share price has surged by 5% and its current market price is Rs 1,397. The BSE IT is up by 1.4%. The top gainers in the BSE IT Index are NIIT TECHNOLOGIES (up 5.3%) and PERSISTENT SYSTEMS (up 5.4%). The top losers are FIRSTSOURCE SOL. (down 0.1%) and TECH MAHINDRA (down 0.2%).
MRPL Plunges by 5%; BSE OIL & GAS Index Down 0.9% (Today's Market)
Aug 20, 2019 03:24 PMMRPL share price has plunged by 5% and its current market price is Rs 51. The BSE OIL & GAS is down by 0.9%. The top gainers in the BSE OIL & GAS Index are CASTROL INDIA (up 0.8%) and INDRAPRASTHA GAS (up 0.4%). The top losers is MRPL (down 5.2%).
ISGEC HEAVY ENG. Surges by 5%; BSE CAPITAL GOODS Index Down 0.5% (Today's Market)
Aug 20, 2019 02:14 PMISGEC HEAVY ENG. share price has surged by 5% and its current market price is Rs 345. The BSE CAPITAL GOODS is down by 0.5%. The top gainers in the BSE CAPITAL GOODS Index is ISGEC HEAVY ENG. (up 5.4%). The top losers are SADBHAV ENGINEERING (down 0.3%) and LAKSHMI MACHINE (down 0.3%).
View More Indian Share Market NewsMost Popular
My Top 3 Dividend Millionaire Stocks(Profit Hunter)
Aug 7, 2019As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.
The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)
Aug 8, 2019This debt-free, well-managed company is all set to soar.
This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)
Aug 12, 2019My experience at the recent AGM of this smallcap company which has financials of any FMCG major.
Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)
Aug 9, 2019Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.
Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)
Aug 12, 2019Only These Smallcaps Will Give Historic Returns in the Future.
More|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "AJANTA PHARMA Plunges by 5%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!